Jon McGrath
RADx Team Lead & CEO, 149 Medical Inc.

Jon is a medtech entrepreneur with over 40 years of experience leading transformative, therapeutic and diagnostic projects and companies. He is a Team Lead within NIH’s RADx Tech and Blueprint Neurotech programs. He was CEO of 149 Medical (noninvasive neonatal monitoring); at Neograft Technologies (adaptive vascular grafts); and at LumeRx (photodynamic transendoscopic treatment for H pylori). Prior to that Jon was an R&D and operations leader at a variety of public and private companies including Biosphere Medical, Urologix, Schneider/Pfizer and Medi-Tech (now Boston Scientific).  He consults with a number of emerging healthcare companies, serves on the IRB and the board of trustees at the BID Plymouth Hospital, and is a catalyst in MIT’s Desphande Center. He has a B.S. in Physics from the University of Vermont.

Evaluation Panel
Selection Committee
No items found.

Let’s build community trust and improve people’s health and well-being.

The NIH Build UP Trust Challenge will award as many as ten Finalists up to $45,000 each and the opportunity to win one of four $200,000 prizes for promising strategies that increase research participation and the adoption of medical care by building trust and improving engagement with historically underserved communities.
Register Now
When you accept, you agree to store cookies to help give you the best experience on our site. See Preferences to change preferences at any time, Read our Cookie Policy for more details.